A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
March 13, 2023
Premier, Inc. Named One of the 2023 World’s Most Ethical Companies® by Ethisphere® for 16th Consecutive Year
Recognized for exceptional leadership and commitment to business integrity through best-in-class ethics, compliance and governance practices.
November 29, 2022
High rates of complications and rehospitalizations after abdominal ostomy surgery
Patient education and WOC nurse specialists could play roles in improving outcomes after ostomy surgery.
November 08, 2022
Five Ways Premier is Helping to Improve the Health of Our Environment
Together with our members, suppliers and other partners, Premier is helping to reduce our climate impact in a number of ways.
June 29, 2022
COVID-19 Marches On: PINC AI™ Continues to Advance Research
PAS continues to spearhead research in understanding outcomes of COVID-19 and its impact on pregnant women, increased risk of myocarditis and healthcare resource utilization.
October 28, 2021
PINC AI™ Data Ties Acute Kidney Injury and Increased Costs to One-third of Hospitalized COVID-19 Patients
There is an urgent need to understand the clinical and economic consequences associated with AKI in hospitalized patients with COVID-19 to better inform treatment decisions...
September 24, 2021
As Delta Surges, Premier Advances COVID-19 Research
The SARS-Cov-2 delta variant has filled U.S. hospitals to capacity reinforcing the need for data to better understand disease severity and support evidence-based treatment decisions...
August 26, 2021
Data Delivered: Collaborating with Pharma to Study Anticoagulant Use in COVID-19 Patients
Premier Applied Sciences and Meitheal Pharmaceuticals collaborate to study anticoagulant use in COVID-19 patients.
July 29, 2021
Overwhelmed U.S. Hospital Systems: A Look Into the Future
Forbes |
A new study conducted via the U.S. Premier Healthcare Database revealed nearly one in every four Covid-19 deaths may be attributed to hospital strain.
July 20, 2021
C2i Genomics and Premier Inc. Team Up to Bring AI-Powered Personalized Cancer Detection and Treatment Monitoring to U.S. Healthcare Providers
See how we're leveraging our rich data sets to uncover new oncology insights.
June 14, 2021
The Alzheimer’s Economy: Is the New $56,000-a-Year Drug Worth It?
Financial Times |
Premier's Roni Christopher weighs in on the FDA's approval of a Biogen treatment for patients with Alzheimer's disease.
May 21, 2021
P. Square Medical Ltd. to Begin Trial Project Using the PeePal™ System with Premier
Premier Applied Sciences to analyze study results and evaluation of the product aimed at improving outcomes and lowering costs for male urinary disorders.
December 22, 2020
Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations
JAMA Network |
This paper examines the uptake and accuracy of diagnosis for COVID-19 in U.S. hospitals.
